Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -111.81% is 50% above its 5-year average of -223.66%, near the high end of its 5-year range (-890.58%–-7.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 146.48% below its 12-month average of -45.36%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -111.81%.
RETURN ON EQUITY (ROE)
-111.81%
RETURN ON EQUITY (ROE) AVG TTM
-45.36%
RETURN ON EQUITY (ROE) AVG 3Y
-33.94%
RETURN ON EQUITY (ROE) AVG 5Y
-223.66%
RETURN ON EQUITY (ROE) AVG 10Y
-302.01%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-146.48%
CURRENT VS 3Y AVG
-229.41%
CURRENT VS 5Y AVG
+50.01%
CURRENT VS 10Y AVG
+62.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-196.88%
vs the sector median at left
GridAI Technologies Corp.
Market Cap
$27.31M
Return on Equity (ROE)
-111.81%
TTM Avg
-45.36%
3Y Avg
-33.94%
5Y Avg
-223.66%
Market Cap
$28.43M
Return on Equity (ROE)
-124.64%
TTM Avg
-100.64%
3Y Avg
-80.07%
5Y Avg
-67.08%
Market Cap
$25.48M
Return on Equity (ROE)
-76.82%
TTM Avg
-235.52%
3Y Avg
-335.24%
5Y Avg
-272.42%
Market Cap
$24.65M
Return on Equity (ROE)
N/A
TTM Avg
-294.82%
3Y Avg
229.70%
5Y Avg
122.55%
Market Cap
$24.44M
Return on Equity (ROE)
-140.55%
TTM Avg
-62.02%
3Y Avg
-44.98%
5Y Avg
-43.41%
Market Cap
$30.65M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.92M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$31.36M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$32.31M
Return on Equity (ROE)
N/A
TTM Avg
333.35%
3Y Avg
376.86%
5Y Avg
270.78%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GridAI Technologies Corp. (GRDX) | $27.31M | -111.81% | -45.36% | -33.94% | -223.66% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -124.64% | -100.64% | -80.07% | -67.08% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -76.82% | -235.52% | -335.24% | -272.42% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | N/A | -294.82% | 229.70% | 122.55% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -140.55% | -62.02% | -44.98% | -43.41% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -132.18% | -94.77% | -38.62% | -46.78% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -120.40% | -43.89% | -83.08% | -65.54% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -86.96% | -27.78% | 5.60% | 57.54% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | N/A | 333.35% | 376.86% | 270.78% |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | N/A | 29.33% | 173.42% | 64.03% |
ROE
-111.8%
ROA
-49.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -111.81% |
| 2026-03-31 | -38.64% |
| 2025-12-31 | -26.96% |
| 2025-09-30 | -18.57% |
| 2025-06-30 | -30.83% |
| 2025-03-31 | -44.08% |
| 2024-12-31 | -31.24% |
| 2024-09-30 | -14.16% |
| 2024-06-30 | -15.22% |
| 2024-03-31 | -7.91% |
| 2023-12-31 | -438.39% |
| 2023-09-30 | -478.22% |
| 2023-06-30 | -890.58% |
| 2023-03-31 | -334.49% |
| 2022-12-31 | -533.51% |
| 2021-06-30 | -563.87% |
| 2021-03-31 | -243.69% |
| 2020-09-30 | -117.69% |
| 2020-03-31 | -518.83% |
| 2019-12-31 | -328.72% |
| 2019-09-30 | -559.56% |
| 2019-06-30 | -552.73% |
| 2019-03-31 | -536.66% |
| 2018-12-31 | -302.50% |
| 2018-09-30 | -216.81% |
| 2018-06-30 | -164.62% |
| 2017-12-31 | -668.22% |
| 2017-09-30 | -509.65% |
| 2017-06-30 | -308.12% |
| 2016-12-31 | -454.14% |
| 2014-12-31 | -0.09% |
